PP
CNST

PDT Partners’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

PDT Partners’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-23,300
Closed -$788K – 982
2021
Q2 		$788K Sell
23,300
-31,519
-57% -$803K 0.05% 415
2021
Q1 		$1.28M Buy
54,819
+19
+0% +$576 0.09% 324
2020
Q4 		$1.58M Buy
+54,800
New +$1.38M 0.11% 268

PDT Partners's CNST Position: Q3 2021 in Review

PDT Partners sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 23,300 shares — an estimated $788K sold.

PDT Partners first reported a position in CNST in Q4 2020 and held it in 3 quarters. The position peaked at $1.58M in Q4 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • PDT Partners reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • PDT Partners sold 23,300 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $788K.
  • PDT Partners first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2020 and held it in 3 quarters.
  • PDT Partners's Constellation Pharmaceuticals, Inc. position peaked at $1.58M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on PDT Partners's 13F filing for Q3 2021, filed 15 Nov 2021.